1. OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial. (15th June 2017) Authors: Wechsler, ME; Akuthota, P; Jayne, D; Khoury, P; Klion, A; Langford, C; Merkel, PA; Moosig, F; Specks, U; Cid, MC; Luqmani, R; Brown, J; Mallett, S; Philipson, R; Yancey, SW; Steinfeld, J; Weller, PF; Gleich, G Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗